Dr. MacCoss has also substantially advanced the area of data-independent (DIA) MS analyses by developing a multiplexed strategy to better isolate noise and improve signal detection and, therefore, sensitivity through observational coherence [3] . One of the most recent projects championed by Dr. MacCoss is a cloud-based application to provide a costeffective mechanism for labs to backup, share, visualize, and analyze data on the cloud called The Chorus Project (http:// chorusproject.org). They are working with developers in academic labs and companies to offer tools to our community that can process mass spectrometry data stored within Chorus. The hope is to provide a platform where all labs have access to the latest analysis tools, and published data can be easily reanalyzed.
To provide a perspective of what drives Mike and how he developed as a scientist, his Ph.D. and postdoc mentors, Dwight Matthews and John Yates, respectively, offered the following commentary on their personal experiences with Mike during his early career.
Dwight Matthews (University of Vermont, UVM): Mike comes from a science family, with his father Malcolm MacCoss being a Ph.D. organic chemist from the UK (University of Birmingham) who originally had worked in Alberta, Canada where Mike was born. He then moved to Chicago to work at Argonne National Lab, before moving to Merck (New Jersey) and rising up through the ranks to Vice President of Basic Chemistry and Drug Discovery Sciences, and the Deputy Site-Head of the MerckRahway Site; later he was appointed Group Vice President for Chemical Research at the Schering-Plough Research Institute.
In summers in college, Mike interned at Merck, first with Pat Griffin, and later with Nathan Yates doing early proteomics research. Mike was focused on getting a Ph.D. with the other BYates^: John Yates, then at the University of Washington, but he was not accepted as a graduate student because of his mediocre undergraduate grades. Why? Because Mike spent most of his time hiking, climbing, back country skiing, and snowshoeing, and he was president of the UVM Outing Club.
Mike somehow got word that I was leaving Cornell Medical College (New York City) to assume a new position here at UVM as Professor of Medicine, with a joint appointment in Chemistry, meaning that I could take graduate students. Mike wrote to me several emails in late May-early June 1996, and he was signed on as a new graduate student for Fall 1996. However, Chemistry has a rule that it won't accept any of its own undergraduate students as graduate students, but an exception was made because I was from the outside and primarily in Medicine. Mike was admitted as a graduate student, but only as an M.S.-level student, which we got changed after a year or so to a Ph.D. track.
Mike was an exceptional student who was on equal footing with my two new postdocs in 1996, and we had a great time together, both working hard together in the lab and playing hard outside in the mountains skiing, although Mike spent much more time outside luring my postdocs out with him. He and one postdoc and another graduate student climbed to the top of every peak in the New Hampshire Presidential Range of the White Mountains in less than 24 h (they are set quite far apart, so it's a lot of hiking), and they did it in winter, but over a couple of days; the Presidential Range includes Mt. Washington that has notoriously bad weather all year round, but it can be a killer in the winter (e.g., 231 mph winds have been recorded there).
Mike was gifted, but he did not want to spend the time I thought he needed to think through details, planning and organizing experiments, and then his results. We had heated words at times over my red marks on his manuscript drafts, with him stomping away and muttering something about "what does it matter anyway" when I would point out his writing was neither precise nor clear enough. I believe he compliments me on giving him this grounding in thinking.
While Mike was a graduate student, his sister Rachel, who later received a Ph.D. in organic chemistry from the University of Cambridge (UK), came to UVM as an undergraduate biology student. I recruited her over to be a chemistry major, and she also worked in my laboratory doing undergraduate research, with her big brother Mike assigned to be her mentor.
Mike was never excited about the hoops the Chemistry graduate program makes you jump through and would grumble about them. One requirement was to prepare and write a grant proposal to be presented to your thesis committee. Most students wrote pretty lame proposals for this exercise (they were novices), but not Mike. He had received word from John Yates, now at Scripps, that he could have a postdoc position with John's group when Mike finished his Ph.D. degree. So Mike prepared an NIH F32 application (entitled BMass Spectrometry Mapping of IRS-1 Phosphorylation^), submitted it to the NIH for work he proposed to do at Scripps, and that was what he submitted to his thesis committee, along with the pink sheet critique containing a fundable priority score. It was a short committee Q&A session after he presented his proposal to his committee. So before Mike finished his Ph.D., he had his own funding as a postdoc in his hands.
I can't say enough about his upward progress and contributions to our discipline and, in particular, in the area of informatics. I am also extremely impressed about how well he has done managing a large diverse group of individuals.
John Yates (The Scripps Research Institute): I first met Mike when he was a summer college intern in Patrick Griffin's laboratory at Merck Research Laboratories in Rahway, NJ. Pat and I went to graduate school together and on a visit to Merck in the late 1990s, Pat introduced me to Mike. Mike worked closely with Pat over a couple of summers and Pat thought very highly of him. As Mike approached graduation, he told me he would apply to graduate school at the University of Washington (UW) with a plan to work in my lab. Unfortunately, despite his impressive undergraduate research experience and my position on the UW Molecular Biotechnology Department's admission committee, Mike was not admitted, possibly because he also had a lot of fun skiing while he was a student in Vermont. The irony is that now Mike is a cherished colleague in the same institution that once turned him down! However, Mike is testament to the fact that sometimes the paths we take are not straight, and the experiences wind up being indispensable down the road. Undeterred by UW's rejection, Mike stayed at the University of Vermont to obtain his Ph.D. with Dwight Matthews before joining my lab for postdoctoral studies. Dwight is an expert in quantitative mass spectrometry who has worked with isotope ratio mass spectrometry for most of his career, and thus Mike got fantastic training in quantitative MS.
When Mike joined my lab, quantitative proteomics was just starting to take off. He submitted an NRSA fellowship application proposing to use quantitative MS to study insulin signaling in collaboration with a biologist he knew from UVM. That proposal was funded, but shortly thereafter his collaborator left UVM, leaving Mike without a biologist for the project. This led to a change in Mike's focus, and he began to develop quantitative proteomic methods as well as software tools to analyze the data generated. When the renowned heavy fly and worm paper came out from Albert Heck's lab [4] , Mike and Christine Wu, another postdoc in the lab at the time, started brainstorming on other animal applications of heavy stable isotope labeling. They came to me proposing to label a rat with 15 N, and I was intrigued enough to encourage and fund the experiment. After the 45-day labeling of the rat with spirulina, we needed to determine how much label was incorporated in the rat's proteins. The Matthews lab was uniquely set up for this experiment, so Mike and Chris flew to Vermont to measure the atomic percent enrichment of the 15 N label in each rat tissue. Their seminal experiment worked well and was published in Analytical Chemistry [5] . This method is now widely used for studies in animal models.
One of the fortunate consequences of this project was that Mike and Chris Wu discovered that they were scientific soul mates. Mike was a great mass spectrometrist and Chris was a tremendous cell biologist, and they collaborated on many interesting projects in my lab, particularly studies looking at membrane proteins and protein modifications. One enduring contribution was work he published that describes the elucidation of post-translational modifications on proteins using a process to generate high sequence coverage [6] . This method uses a combination of three enzymes together with LC/LC/MS/ MS and is nicknamed Btriple digestion.^For proteins and protein complexes, this method can generate 95% + sequence coverage of proteins, enabling comprehensive identification of PTMs. This method has solved so many difficult problems in the lab that the running joke is that Btriple digestion^is the solution to all problems.
It was immediately and abundantly clear from the time he stepped in my lab that Mike was going to be a success. In fact, when UW had an opening for a proteomics person, I enthusiastically suggested that they consider Mike. As soon as he interviewed, UW recognized his talent and hired him immediately (after fulfilling all the legal requirements for a fair and equitable search!). Mike made an immediate impact at UW and shortly after he was hired, he was chosen to replace Ruedi Aebersold in an NIH P41 center I was a part of. Since Mike and I have been part of this center for over 10 years, I have had the privilege of witnessing his professional development closely. Under the guidance and mentoring of his wonderful chairman Bob Waterston, Mike has flourished at UW. It's no surprise to me or anyone else that Mike lived up to the promise he showed in my lab and is as accomplished as he is today.
The subject of this Special Focus Issue is to feature developments in mass spectrometry data acquisition and informatics to advance proteomics and other omics-based research, with invited articles contributed by Mike's friends and colleagues.
( Louis [where he commented that BThis is actually the first time I've ever worn a suit to give a talk, so it must be important( Figure 1 )], he emphasized that proteomics will continue to require informatics tools, and these tools need to be well engineered, supported, and documented. He encouraged the research community to build upon each other's work and not try to make a new tool that does the same thing better. Data needs to be stored in a common location (across all vendors), and perhaps most importantly, the field will advance more efficiently by better communication with colleagues in computational disciplines to help them better understand our data and our needs. Mike is certainly a leading advocate to promote the development of informatics tools for mass spectrometry that can be used to advance all of the omics-fields.
Given the fact that Mike is an academic Bgreat-grandchildô f Professor Klaus Biemann (Mike's Ph.D. mentor, Dwight Matthews, received his Ph.D. from John Hayes at Indiana University, who received his Ph.D. from Professor Biemann at MIT), and his postdoc mentor, John Yates, received the ASMS Biemann Medal in 2004, it is fitting for Mike MacCoss to have received the Biemann Medal. On behalf of the editors at JASMS and Mike's friends and former and present colleagues, we congratulate Mike for his much-deserved award.
